Company Overview and News

 
How Mining Stocks Performed on April 16

2018-04-17 marketrealist
Usually, precious metal mining companies follow precious metals for price direction. Precious metals increased on Monday, April 16, 2018, which was followed by most mining shares.

 
Geopolitical Tensions and Volatility: Impact on the Market

2018-04-17 marketrealist
Geopolitical tensions, trade war fears, rate hikes, and market volatility have left investors restless. Geopolitical issues started when President Trump imposed tariffs on steel and aluminum imports. The issues increased due to a potential trade war between the United States and China. Next, President Trump targeted Russia. Sanctions have been imposed on several Russian entities, including aluminum giant RUSAL.

 
How Precious Metals and Miners Are Reacting to Syrian Unrest

2018-04-17 marketrealist
Gold rose again on April 16, 2018, but it was a marginal increase compared to the previous trading session. Spot gold rose 0.03%, while futures for April expiration increased 0.2% and closed at $1,347.50 per ounce. Palladium joined gold and rose 2.3%, ending the day at $1,004.80 per ounce and surpassing the $1,000 mark again. Palladium has had gains of almost 7.6% over the past five trading days.

3
Golden Star Resources upgraded to outperform from market perform at BMO Capital

2018-04-16 marketwatch
The housewares retail chain was a disruptive 20th century retailer. In the 21st century, however, it’s found itself disrupted

1
Following Metals, Miners Saw an Upswing on April 11

2018-04-12 marketrealist
Usually, precious metals mining companies follow precious metals. When precious metals rose on April 11, 2018, miners followed suit. Most miners saw an up day on April 11, though that may not always be the case.

 
Is the Correlation of Mining Shares Mixed or Directional?

2018-04-11 marketrealist
In this part of our series, we’ll look at the correlation between gold and four mining stocks: Coeur Mining (CDE), Barrick Gold (ABX), Kinross Gold (KGC), and Eldorado Gold (EGO). Mining stocks mostly move with gold prices but not always. Among these four miners, Kinross Gold has shown the highest correlation with gold, while Eldorado Gold has seen a negative correlation to gold on a YTD (year-to-date) basis.

 
Are US-China Jitters Affecting Precious Metals?

2018-04-10 marketrealist
Gold, silver, platinum, and palladium increased 0.33%, 1%, 2.4%, and 4.2%, respectively, on Monday. Gold futures for April expiration were trading at $1,336.3 an ounce on Monday, April 9. The volatility in gold was at 10.4%, while its RSI level was at 59.7. Silver futures for April expiration closed at $16.5 per ounce. Silver’s volatility was at 17.4% and its RSI level was at 58. Platinum and palladium were at $933.

 
Portfolio Sizing: A Top Key To Trading Success - Part 2

2018-04-09 seekingalpha
Large losses and irresponsible position sizing are not only damaging to the account, they are extremely damaging to a trader's mental capital.

1
Citing Gold Mine Verdict, New Democracy Says SYRIZA Anti-Investor

2018-04-08 thenationalherald
In this undated photo provided on Monday, Sept. 11, 2017, by Hellas Gold company, employees work inside a gold mine complex in Skouries, in the Halkidiki peninsula, northern Greece. (Hellas Gold via AP)

1
How Mining Stocks Have Performed in April So Far

2018-04-06 editors.aws.marketrealist
Initially, the Fed’s decision to raise the interest rate didn’t affect miners and metals much. But over the past week, both metals and miners have been choppy.

3
EGO / Eldorado Gold Corporation ELDORADO GOLD CORPORATION - 6-K (Current Report of Foreign Issuer)

2018-04-05 sec.gov
JA Filed by Filing Services Canada Inc. 403-717-3898 FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.

2
Eldorado Gold: The Positive Arbitration Ruling Is Just The Beginning

2018-04-05 seekingalpha
Eldorado Gold should focus on Lamaque and Kisladag and leave Skouries at care and maintenance at least by 2022.

2
Eldorado Gold Confirms Positive Arbitration Ruling

2018-04-04 seekingalpha
The Panel's ruling rejects the Greek State's motion that the technical study for the Madem Lakkos metallurgy plant for treating Olympias and Skouries concentrates.

 
EGO / Eldorado Gold Corporation ELDORADO GOLD CORPORATION - 6-K (Current Report of Foreign Issuer)

2018-04-04 sec.gov
JA Filed by Filing Services Canada Inc. 403-717-3898 FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.

 
US Dollar: Its Strong Correlation to Gold in the Past Month

2018-04-04 editors.aws.marketrealist
Gold prices fell 0.11% on Thursday, March 29, 2018, and closed at $1,322.80 per ounce. Its call-implied volatility remained at 9.1%, while its RSI (relative strength index) level was 51.5. Gold continues to trade above its 100-day moving average but below its 20-day moving average due to the ongoing slump in gold.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 284902103